EPO appeals board weighs-up Broad’s CRISPR claims

14-01-2020

Rory O'Neill

EPO appeals board weighs-up Broad’s CRISPR claims

servickuz / shutterstock.com

The first day of a landmark hearing on CRISPR ownership dealt nearly exclusively with untangling linguistic arguments, lawyers following the proceedings told LSIPR.


CRISPR, CRISPR/Cas9, European Patent Office, EPO, Broad Institute, appeals board, priority, Luciano Marraffini

LSIPR